Law and the Regulation of Medicines

The principal purpose of this book is to tell the story of a medicine’s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed beca...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Jackson, Emily
Médium: E-kniha Kniha
Jazyk:angličtina
Vydáno: London Bloomsbury Publishing (UK) 2012
Hart Publishing Ltd
Hart
Bloomsbury Publishing Plc
Bloomsbury Publishing
Hart Publishing
Vydání:1
Témata:
Access to health care
Drug accessibility > Great Britain
Drugs
Drugs > Law and legislation > Great Britain
Great Britain
Law
Law and legislation
Legislation
Medical care
Medical Humanities & Medical History
Medical Law and Ethics
Medical research
Medicine
Pharmaceutical industry
Pharmaceuticals
Pharmacology
Pharmacy
Pharmacy > Law and legislation > Great Britain
Public health
Regulation
United Kingdom
ISBN:147420077X, 9781474200776, 9781849461795, 1847319084, 1849461791, 9781847319081
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The principal purpose of this book is to tell the story of a medicine’s journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine’s regulation are examined separately: first, pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and second, the possibility of using medicines to enhance well-being or performance, rather than treat disease. Throughout, the emphasis is on the role of regulation in shaping and influencing the operation of the medicines industry, an issue that is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources.
Bibliografie:medicalLawEthics; txt
Bibliography: p. 267-292
Some copies have different pagination: xvi, 302 p. (Additional pages: Index p.293-302)
SourceType-Books-1
ObjectType-Book-1
content type line 7
ISBN:147420077X
9781474200776
9781849461795
1847319084
1849461791
9781847319081
DOI:10.5040/9781474200776